KIDS Relative Valuation
KIDS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KIDS is overvalued; if below, it's undervalued.
Historical Valuation
OrthoPediatrics Corp (KIDS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -43.45. The fair price of OrthoPediatrics Corp (KIDS) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：18.17
Fair
-13.72
PE
1Y
3Y
5Y
Trailing
Forward
20.00
EV/EBITDA
OrthoPediatrics Corp. (KIDS) has a current EV/EBITDA of 20.00. The 5-year average EV/EBITDA is 273.27. The thresholds are as follows: Strongly Undervalued below -587.18, Undervalued between -587.18 and -156.96, Fairly Valued between 703.49 and -156.96, Overvalued between 703.49 and 1133.72, and Strongly Overvalued above 1133.72. The current Forward EV/EBITDA of 20.00 falls within the Historic Trend Line -Fairly Valued range.
-18.96
EV/EBIT
OrthoPediatrics Corp. (KIDS) has a current EV/EBIT of -18.96. The 5-year average EV/EBIT is -50.24. The thresholds are as follows: Strongly Undervalued below -108.75, Undervalued between -108.75 and -79.50, Fairly Valued between -20.99 and -79.50, Overvalued between -20.99 and 8.26, and Strongly Overvalued above 8.26. The current Forward EV/EBIT of -18.96 falls within the Overvalued range.
1.76
PS
OrthoPediatrics Corp. (KIDS) has a current PS of 1.76. The 5-year average PS is 5.97. The thresholds are as follows: Strongly Undervalued below -0.52, Undervalued between -0.52 and 2.73, Fairly Valued between 9.22 and 2.73, Overvalued between 9.22 and 12.46, and Strongly Overvalued above 12.46. The current Forward PS of 1.76 falls within the Undervalued range.
0.00
P/OCF
OrthoPediatrics Corp. (KIDS) has a current P/OCF of 0.00. The 5-year average P/OCF is -16.33. The thresholds are as follows: Strongly Undervalued below -188.04, Undervalued between -188.04 and -102.18, Fairly Valued between 69.53 and -102.18, Overvalued between 69.53 and 155.38, and Strongly Overvalued above 155.38. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
OrthoPediatrics Corp. (KIDS) has a current P/FCF of 0.00. The 5-year average P/FCF is -3.18. The thresholds are as follows: Strongly Undervalued below -31.37, Undervalued between -31.37 and -17.27, Fairly Valued between 10.91 and -17.27, Overvalued between 10.91 and 25.00, and Strongly Overvalued above 25.00. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
OrthoPediatrics Corp (KIDS) has a current Price-to-Book (P/B) ratio of 1.30. Compared to its 3-year average P/B ratio of 1.93 , the current P/B ratio is approximately -32.49% higher. Relative to its 5-year average P/B ratio of 2.98, the current P/B ratio is about -56.29% higher. OrthoPediatrics Corp (KIDS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -5.90%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -4.52% , the current FCF yield is about -100.00% lower.
1.30
P/B
Median3y
1.93
Median5y
2.98
-6.55
FCF Yield
Median3y
-5.90
Median5y
-4.52
Competitors Valuation Multiple
The average P/S ratio for KIDS's competitors is , providing a benchmark for relative valuation. OrthoPediatrics Corp Corp (KIDS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 12.23%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of KIDS decreased by 21.61% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -14.51 to -19.22.
The secondary factor is the Revenue Growth, contributed 12.23%to the performance.
Overall, the performance of KIDS in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is OrthoPediatrics Corp (KIDS) currently overvalued or undervalued?
What is OrthoPediatrics Corp (KIDS) fair value?
How does KIDS's valuation metrics compare to the industry average?
What is the current P/B ratio for OrthoPediatrics Corp (KIDS) as of Dec 05 2025?
What is the current FCF Yield for OrthoPediatrics Corp (KIDS) as of Dec 05 2025?
What is the current Forward P/E ratio for OrthoPediatrics Corp (KIDS) as of Dec 05 2025?